Esophageal Cancer Tissue Banking
ESBX
Prospective Collection of Health Information and Biospecimens in Esophageal Cancer
1 other identifier
observational
311
1 country
1
Brief Summary
To create an esophageal cancer biospecimen repository that will collect, annotate, store and distribute human esophageal cancer biospecimens in a manner that embraces the highest ethical standards of human subject's research, that conforms to the best practices of biorepository science and that furthers basic, translational and clinical research in the understanding diagnosis and treatment of this disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2011
CompletedFirst Submitted
Initial submission to the registry
January 29, 2013
CompletedFirst Posted
Study publicly available on registry
January 31, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2021
CompletedAugust 9, 2022
August 1, 2022
10.4 years
January 29, 2013
August 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prospective Database
A prospective database which would be maintained in the Division of Cardiothoracic Surgery would be able to link clinical outcomes to processed tissues (pathologic specimens, research specimens and plasma) enabling higher level correlation studies to be performed. Proper use of such a resource will aid considerably in our ability to advance our field and care for our future patients with esophageal cancer.
five years
Eligibility Criteria
Subjects will be identified by participating staff in the clinics of the surgical oncology or medical oncology clinics, and patients referred to the endoscopy center, and provided information about the biorepository.
You may qualify if:
- Adults with known or suspected esophageal cancer who are willing and able to give written informed consent for biospecimen collections.
- Age ≥ 18 years
- Must be willing and able to sign an informed consent document
You may not qualify if:
- Pediatric patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Publications (2)
Edwards FH. The STS database at 20 years: a tribute to Dr Richard E. Clark. Ann Thorac Surg. 2010 Jan;89(1):9-10. doi: 10.1016/j.athoracsur.2009.11.028. No abstract available.
PMID: 20103196BACKGROUNDFerguson TB Jr, Dziuban SW Jr, Edwards FH, Eiken MC, Shroyer AL, Pairolero PC, Anderson RP, Grover FL. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg. 2000 Mar;69(3):680-91. doi: 10.1016/s0003-4975(99)01538-6.
PMID: 10750744BACKGROUND
Biospecimen
peripheral blood and Esophageal Tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2013
First Posted
January 31, 2013
Study Start
January 25, 2011
Primary Completion
June 30, 2021
Study Completion
October 29, 2021
Last Updated
August 9, 2022
Record last verified: 2022-08